Skip to main content
Premium Trial:

Request an Annual Quote

NIDCR to Award $2.5M Through 2009 to Use Gene Silencing for Oral Disease

NEW YORK (GenomeWeb News) - The National Institute of Dental and Craniofacial Research plans to award $2.5 million over two years to support the application of gene silencing to prevent and treat oral and craniofacial disorders and disease.
 
In a funding announcement released Friday, NIDCR said it is seeking research projects that will use “simple genetic interventions,” including RNA interference, to “modify the expression of genes associated with oral, dental, and craniofacial diseases and disorders.”
 
Applicants “should demonstrate that the proposed oligonucleotide-based approaches directly influence molecular, biochemical, electrophysiological or other functional changes in a condition that falls within the NIDCR mission area,” the institute said. These areas include tooth and bone disorders, oral cancer, chronic inflammatory conditions, viral infections, autoimmune disorders, craniofacial birth defects, acute and chronic pain conditions, salivary gland dysfunction, and other oral, dental, and craniofacial disorders.
 
NIDCR said it plans to award around $2.5 million in fiscal years 2008 and 2009 to between five and 10 grants, pending availability of funds.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.